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Recent evidence suggests that insulin may influence many brain
functions. It is known that intracerebroventricular (icv) injection of
nondiabetogenic doses of streptozotocin (STZ) can damage insulin
receptor signal transduction. In the present study, we examined the
functional damage to the brain insulin receptors on central mechan-
isms regulating glomerular filtration rate and urinary sodium excre-
tion, over four periods of 30 min, in response to 3 µl insulin or 0.15
NaCl (vehicle) injected icv in STZ-treated freely moving Wistar-
Hannover rats (250-300 g). The icv cannula site was visually con-
firmed by 2% Evans blue infusion. Centrally administered insulin
(42.0 ng/µl) increased the urinary output of sodium (from 855.6 ± 85.1
to 2055 ± 310.6 ∆%/min; N = 11) and potassium (from 460.4 ± 100 to
669 ± 60.8 ∆%/min; N = 11). The urinary sodium excretion response
to icv insulin microinjection was markedly attenuated by previous
central STZ (100 µg/3 µl) administration (from 628 ± 45.8 to 617 ±
87.6 ∆%/min; N = 5) or by icv injection of a dopamine antagonist,
haloperidol (4 µg/3 µl) (from 498 ± 39.4 to 517 ± 73.2 ∆%/min; N =
5). Additionally, insulin-induced natriuresis occurred by increased
post-proximal tubule sodium rejection, despite an unchanged glo-
merular filtration rate. Excluding the possibility of a direct action of
STZ on central insulin receptor-carrying neurons, the current data
suggest that the insulin-sensitive response may be processed through
dopaminergic D1 receptors containing neuronal pathways.
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Chronic elevated plasma insulin levels
and resistance to the hypoglycemic effect of
insulin are associated with increased blood
pressure in human and animal models of
hypertension. This observation has led to the
speculation that insulin may play a role in the
development of increased blood pressure
(1,2). On the other hand, the role of the CNS
in the control of blood pressure and hydro-
saline homeostasis has been demonstrated
by several studies (3,4). Recently, increasing
evidence has suggested not only that insulin
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is vital to the brain but that the hormone may
also exert an influence by modulating many
brain functions, such as food intake regula-
tion and cardiovascular function (1,2,5).
Evidence for a selective insulin transport
mechanism across the blood-brain barrier
and its localization in specific brain regions
supports a CNS regulatory function for insu-
lin-related peptides (6-8).
We have recently demonstrated the in-
volvement of insulin-induced insulin recep-
tor and post-receptor protein phosphoryla-
tion in the action of insulin in rat hypothala-
mus (9). The peripheral action of insulin has
been shown to reduce urinary sodium excre-
tion, suggesting an attractive link between
the renal effects of insulin, low urinary so-
dium excretion and the development and/or
maintenance of arterial hypertension. We, as
well as others (5,10,11), have shown that
acute intracerebroventricular (icv) injection
of insulin significantly decreased blood pres-
sure, heart rate and renal sodium reabsorp-
tion, with corresponding reductions in renal
sympathetic nerve activity in anesthetized
rats. However, there is little information on
the neural mechanisms mediating the effects
of icv insulin administration on renal sodium
handling by rats (10).
Functional damage to the neuronal insu-
lin receptor signal transduction in the CNS
comparable to type 2 diabetes mellitus has
been established by icv injection of strepto-
zotocin (STZ) in rats at levels below those
producing diabetes (12). Also, a decrease in
dopamine content and D1 receptor density
has been demonstrated (13) in STZ-treated
animals. Like cocaine, insulin or a nonapep-
tide C-terminus of the insulin ß-chain strongly
inhibits dopamine uptake by the rat dopa-
mine transporter stably expressed in Chinese
hamster ovary cells (designated D8 cells).
This inhibitory effect was also confirmed by
experiments on striatal synaptosomes (14).
Thus, we may hypothesize that CNS insulin
and insulin-derived peptides are neuropep-
tides acting on neuronal insulin receptors
and/or as neuropeptide precursors that may
interact with the dopamine neuronal path-
ways to promote changes in renal sodium
excretion.
In the present study, we examined the
functional damage to the neuronal insulin
receptor signal transduction on central
mechanisms regulating urinary sodium ex-
cretion in icv STZ-treated rats. For this pur-
pose, we assessed the effect of acute icv
insulin administration on tubular sodium
handling in unanesthetized, unrestrained rats.
Rats were randomly assigned to six
groups: a) icv 0.15 M NaCl-injected rats (N
= 11), b) icv 42.0 ng/µl insulin-injected rats
(N = 11), c) STZ-treated rats (100 µg/3 µl)
injected icv with 0.15 M NaCl (N = 5), or d)
with insulin (N = 5), e) subcutaneously (sc)
insulin-injected rats (N = 5), and f) icv 4 µg/
3 µl haloperidol-treated rats (N = 5). The
general guidelines established by the Brazil-
ian College of Animal Experimentation
(COBEA) were followed throughout the
study.
Male Wistar-Hannover rats (250-300 g)
were chronically instrumented with an icv
guide cannula (4,15) and maintained under
controlled temperature and lighting condi-
tions in individual metabolic cages, with
free access to tap water and standard labora-
tory rodent chow. Briefly, the animals were
anesthetized with an intraperitoneal injec-
tion of sodium pentobarbital (50 mg/kg body
weight) and a stainless steel cannula was
stereotaxically implanted into the lateral ce-
rebral ventricle 6 days before the experi-
ments, using previously reported techniques
and pre-established coordinates (4,10): an-
teroposterior 0.2 mm from bregma; lateral
1.5 mm, and vertical 4.0 mm. The position of
the cannula was visually confirmed by 2%
Evans blue infusion through the icv cannula
at the end of the experiment. STZ (100 µg/
3 µl) was microinjected icv 7 days before
administration of 42.0 ng/µl insulin.
Fourteen hours before the renal test, 60
µmol LiCl/100 g body weight was given by
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gavage. After an overnight fast, each animal
received a load of tap water by gavage (5%
of body weight), followed by a second load
of the same volume 1 h later. Thirty minutes
after the second load (control period), ve-
hicle (0.15 M NaCl) or insulin (100 U/ml,
206 mOsm/kg H2O; Eli Lilly, São Paulo, SP,
Brazil) was microinjected in the volume of
3 µl at the concentration of 42.0 ng/µl with a
10-µl Hamilton microsyringe and spontane-
ously voided urine was collected over four
periods of 30 min into a graduated centrifuge
tube.
At the end of the experiment, the animals
were anesthetized with sodium pentobar-
bital, blood was drawn by cardiac puncture,
and urine and plasma samples were obtained
for analysis. Plasma and urine sodium, po-
tassium and lithium concentrations were
measured by flame photometry using a B262
Micronal Instrument (São Paulo, SP, Bra-
zil), while creatinine concentrations and cere-
brospinal fluid osmolarity were determined
with a spectrophotometer (Micronal Instru-
ment) and a wide-range osmometer (Ad-
vanced Inst. Inc., Norwood, MA, USA), re-
spectively. Insulin levels were measured by
radioimmunoassay (Diagnostic Products
Corp., Los Angeles, CA, USA) and plasma
glucose concentration by an enzymatic
method (Labtest, Campinas, SP, Brazil).
Creatinine clearance (CCr) was used to esti-
mate glomerular filtration rate and lithium
clearance (CLi) was used to assess proximal
tubule output (4,10). Fractional sodium ex-
cretion was calculated as CNa/CCr, where
CNa is sodium clearance. The fractional
proximal and post-proximal sodium excre-
tion were calculated as CLi/CCr x 100 and
CNa/CLi x 100, respectively. Renal param-
eter responses to icv insulin were calculated
as the area under the curve versus time, with
renal data reported as a percent of their
baseline value during the 30-min control
period preceding each experimental interval.
Statistical analysis of the data was per-
formed using ANOVA for repeated meas-
urements followed by the Bonferroni post
hoc test to determine the extent of the differ-
ences. A P value ≤0.05 was considered to
indicate statistical significance.
Figure 1 and Table 1 show the effects of
icv and sc insulin or 0.15 M NaCl microin-
jection with or without previous STZ treat-
ment on renal sodium and potassium han-
dling, glycemia and insulinemia levels ex-
pressed as mean ± SEM per 100 g body
weight. All rats survived and were clinically
healthy up to the sixth day after the cannula
was positioned into the lateral cerebral ven-
Table 1. Effect of intracerebroventricular (icv) and subcutaneous (sc) insulin (Ins, 42 ng/µl) or icv NaCl injection
(control, 0.15 M) in sham-operated rats on cerebrospinal fluid (CSF) osmolarity, serum sodium, potassium and
lithium levels, and insulinemia and glycemia compared to the administration of insulin (STZ + Ins, 42.0 ng/µl)
in streptozotocin-treated rats.
Group Sodium Potassium Lithium Insulinemia Glycemia CSF osmolarity
(mM) (mM) (µM) (AUC) (AUC) (mOsm/kg H2O)
Control (icv, N = 11) 143 ± 2.2 4.1 ± 0.3 85 ± 13 14.91 ± 2.78 436 ± 21 306 ± 2.0
Ins (icv, N = 11) 145 ± 2.4 3.9 ± 0.4 60 ± 10 18.48 ± 2.02 298 ± 27* 301 ± 3.0
STZ + Ins (icv, N = 5) 143 ± 2.9 4.0 ± 0.7 140 ± 30 15.21 ± 3.34 387 ± 46 ND
Ins (sc, N = 5) 143 ± 3.5 3.5 ± 0.2 100 ± 10 13.2 ± 1.2 391 ± 37 ND
Data are reported as means ± SEM. AUC = area under the curve. ND = not determined. N = 5 for all
measurements except insulinemia (Ins, icv, N = 6), glycemia (N = 7) and CSF osmolarity (N = 3).
*P ≤ 0.05 compared to respective control (ANOVA and Bonferroni post hoc test).
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tricle. There were no significant differences
in cerebrospinal fluid osmolarity, serum so-
dium, potassium or lithium levels (Table 1)
between icv 0.15 M NaCl-injected rats and
the other groups.
The urinary flow rates and the glomeru-
lar filtration rate estimated by CCr did not
differ significantly among groups during the
studies of renal tubule sodium handling (Fig-
ure 1). The icv microinjection of insulin
(42.0 ng/µl) increased urinary fractional so-
dium excretion (from 855.6 ± 85.1 to 2055 ±
310.6 ∆%/min) and fractional potassium ex-
cretion in insulin-injected rats (from 460.4 ±
100 to 669 ± 60.8 ∆%/min). The urinary
sodium excretion response to icv insulin in-
jection was significantly attenuated by pre-
vious icv administration of 100 µg/3 µl STZ
in rats (from 628 ± 45.8 to 617 ± 87.6 ∆%/
min) (Figure 1). The enhanced fractional
sodium and potassium excretions were ac-































































































Figure 1. Effect of intracerebroventricular (icv,
N = 11) and subcutaneous (sc, N = 5) insulin
(Ins, 42 ng/µl) injection or icv 0.15 M NaCl injec-
tion (control) on creatinine clearance (CCr), frac-
tional sodium excretion (FENa), proximal (FEPNa)
and post-proximal (FEPPNa) fractional sodium
excretion and fractional potassium excretion
(FEK) compared to administration of 0.15 M NaCl
(STZ, N = 15) or insulin (STZ + Ins, 42.0 ng/µl, N
= 5) in STZ-treated rats. Data are reported as
means ± SEM. AUC, area under the curve; STZ,
streptozotocin. *P ≤ 0.05 (ANOVA and Bonfer-
roni post hoc test).
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proximal sodium rejection compared with
the sham-operated icv 0.15 M NaCl-injected
rats. This increase occurred despite an un-
changed CCr and fractional proximal so-
dium excretion (Figure 1). The high frac-
tional sodium excretion induced by icv insu-
lin injection was blunted and significantly
reduced by previous icv STZ administration
(P < 0.01) (see Figure 1). This attenuated
urinary ion excretion was associated with a
significant decrease in proximal and post-
proximal sodium rejection (Figure 1). Con-
firming previous studies, the renal natriuret-
ic responses were not altered by icv 0.15 M
NaCl administration. Likewise, CCr, natri-
uresis and kaliuresis were unaffected by in-
sulin administered sc (Figure 1). Repeated
icv microinjection of 42.0 ng/µl insulin
caused reproducible decreases in glycemia
levels (P < 0.03) (Table 1). On the other
hand, insulinemia was not altered by icv
insulin or 0.15 M NaCl microinjection (Table
1). Supporting the possibility that the action
of insulin on the CNS may be modulated by
central dopaminergic receptors, we demon-
strated that the urinary sodium excretion
response to icv insulin microinjection was
markedly attenuated by 20-min previous icv
injection of a dopamine antagonist, halo-
peridol (4 µg/3 µl; from 498 ± 39.4 to 517 ±
73.2 ∆%/min) accompanied by an unchanged
glomerular filtration rate (CCr). There were
no significant changes in kaliuresis in halo-
peridol + insulin-treated animals.
The fact that lesions of hypothalamic
nuclei produce hyperinsulinemia and insulin
resistance suggests a major role for the CNS
in the regulation of insulin action and secre-
tion. On the other hand, several lines of
evidence indicate that hyperinsulinemia pro-
duces sympathetic activation in both hu-
mans and rats (5,15). In the current study, we
demonstrated that centrally administered in-
sulin produced substantial increases in the
urinary output of sodium, lithium and potas-
sium, and tested the hypothesis that the cen-
trally insulin-induced renal ion excretion
may, at least in part, be related to changes in
CNS dopaminergic receptor integrity. In ad-
dition, we showed that insulin-induced natri-
uresis occurred by increasing post-proximal
tubule sodium rejection despite an unchanged
CCr (Figure 1) and was proportional to the
sodium filtered load. Thus, the observed
increase in renal fractional sodium and po-
tassium excretions may be due to the inabil-
ity of renal tubules to handle the electrolytes,
with a consequent disruption in glomerulo-
tubular balance.
It has been shown that insulin infused
into the cerebroventricular space can reach
neuronal loci after passing between ependy-
mal cells or glial processes, to enter the
interstices of the underlying cerebral neuro-
pil (6-8). Injection of labeled insulin into the
cerebral ventricles of rats produced heavy
staining in regions closer to the third ven-
tricle. In vivo and in vitro autoradiographic
techniques have identified insulin-specific
binding sites in the median eminence (8), the
dorsomedial hypothalamus, the arcuate
nucleus and the ventromedial hypothalamus
(16). Although a physiological role of cen-
tral insulin remains to be identified, insulin
binding to axonal or synaptic receptors in the
CNS influences hypothalamic norepineph-
rine release and peripheral autonomic func-
tion (11). Studies have shown that the injec-
tion of insulin into the periventricular area
significantly reduces the efferent firing rate
of peripheral sympathetic nerves and that
this hypothalamic effect of insulin is abol-
ished when neurons are destroyed by injec-
tion of kainic acid (11). It has also been
demonstrated that icv injection of methyl-
atropine suppresses the insulin responses to
an oral glucose load in rats (17). We, as well
as others (4,18), have shown that carbachol
and norepinephrine injection into the septal
area, anterior lateral hypothalamus, and sub-
fornical organ as well as the anterior portion
of the third ventricle induces a dose-related
natriuresis accompanied by a lesser degree
of kaliuresis (18).
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All of these findings led us to hypoth-
esize that the natriuresis observed in the
present study may result from a significant
and transient renal sympathetic inhibition or
indirectly from a contribution of sympathetic
and parasympathetic nervous system activa-
tion. In the present study, a possible indirect
mechanism underlying the increase in renal
sodium excretion includes insulin-induced
changes in CNS glucose metabolism. Sup-
porting such a mechanism, glucose depriva-
tion in the CNS generated by icv injection of
2-deoxy-D-glucose increased peripheral au-
tonomic nervous system activity in rats (19).
However, an experiment using relatively
large doses of icv insulin or cultured neurons
labeled with radioactive 2-deoxy-D-glucose
supported the traditional view that the brain
is not responsive to insulin with respect to
glucose uptake and metabolism (20). Fur-
thermore, in a recent study, relatively large
doses of icv insulin did not change peripher-
al neural activity, supporting our conclusion
that the insulin effect in the present study
was not mediated by glucose deprivation.
We showed that central insulin by itself
decreased blood glucose levels, with no
change in insulinemia. Intracerebroventricu-
lar application of low, nondiabetogenic doses
(<500 µg/kg) of STZ is followed by alter-
ations of the dopaminergic system in the rat
striatum (13,14). In this brain region the
dopamine content and dopaminergic D1 re-
ceptors were significantly decreased 7 days
after icv administration of STZ compared to
control (13,14). The findings of the present
study suggest that dopaminergic receptors
may, at least in part, modulate insulin signal-
ing mechanisms associated with a rise of
post-proximal sodium rejection (Figure 1),
after central insulin injection. Since nondia-
betogenic icv administration of STZ pro-
duces changes in striatal dopamine content
and D1 receptor density, this system might
be related to alterations of the brain insulin
circuit, and in the present study in particular
to the blunted urinary sodium excretion re-
sponse in previously STZ-treated rats. This
statement may also be supported by the at-
tenuated urinary sodium excretion response
to icv insulin microinjection after previous
icv haloperidol administration shown in the
present study.
However, other possibilities should be
examined. First, a direct effect of STZ on
insulin receptor-carrying neurons must be
ruled out. Second, in view of the wide spec-
trum of STZ toxicity, other neurotransmitter
systems or neuronal ensembles might also
be compromised by STZ pretreatment. Re-
cently, it has been shown that many brain-
specific natriuretic factors are located in peri-
ventricular structures related to water and
salt balance control (3,4,18), indicating a
possible link between insulin and natriure-
sis. Since the mechanism of the STZ-attenu-
ated natriuretic response in centrally insulin-
injected rats is still unclear, investigations
directed at finding insulin-sensitive path-
ways in periventricular areas may contribute
to improving our understanding of the link
between hypertension, sodium handling and
diabetes.
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